Search - tctmd.com

Displaying 141 - 160 of 168

Sort: Relevancy | Date

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

Presentation TVT 2022

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

Presenter: Joao Cavalcante

June 08, 2022

Tailoring TEER: Imaging for Clip Selection

Presentation TVT 2022

Tailoring TEER: Imaging for Clip Selection

Presenter: Fabien Praz

June 08, 2022

CT for Adjudication TEER Feasibility and More

Presentation TVT 2022

CT for Adjudication TEER Feasibility and More

Presenter: Omar Khalique

June 08, 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presentation TVT 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presenter: D. Scott Lim

June 08, 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

From GA to MAC: TEE to ICE – Techniques, Image Interpretation, Strengths, and Weaknesses of ICE for Left Atrial Appendage Occlusion

Presentation TVT 2022

From GA to MAC: TEE to ICE – Techniques, Image Interpretation, Strengths, and Weaknesses of ICE for Left Atrial Appendage Occlusion

Presenter: Carlos Sanchez

June 08, 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

May 22, 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

COVID-19: TCTMD’s Dispatch for May Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for May Week 3

May 16, 2022

As TAVI Turns 20, How Has the Heart Team Evolved?

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

The Expanding Role of Advanced Imaging Modalities in Pre-procedural Planning in SHD Transcatheter Edge-to-Edge MitraClip Repair (TEER)

Presentation ARCH 2022

The Expanding Role of Advanced Imaging Modalities in Pre-procedural Planning in SHD Transcatheter Edge-to-Edge MitraClip Repair (TEER)

Presenter: James B. Hermiller

April 23, 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

New HF Guidelines Stress Four Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 01, 2022

Alice Soohyun Chang, MD

News Featured Fellow

Alice Soohyun Chang, MD

Yael L. Maxwell

March 18, 2022

COVID-19: TCTMD’s Dispatch for March Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 2

March 07, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 2

February 07, 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

News Conference News STS 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

February 03, 2022

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Presentation THT 2022

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Presenter: Mark Reisman

February 02, 2022

Omecamtiv Mecarbil--Is It More Effective in Low EFs and Is It Better Than Digoxin?

Presentation THT 2022

Omecamtiv Mecarbil - Is It More Effective in Low EFs

Presenter: John Teerlink

February 01, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.